SkinHealth Systems Inc.
10.88USD
-0.2150 (-1.94%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on SKIN.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0 | $0 | 0 | 0 |
| Next quarter | -$0.42▼ | -$0.33 | 1 | 0 |
| Current year | $2.56▲ | $2.2 | 1 | 0 |
| Next year | $3.82▲ | $3 | 1 | 0 |
Beat in 1 of the last 2
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2025-12-31 | -$1.09 | -$1.2 | -0.11 (-10.1%) |
| 2025-09-30 | -$1 | $0.57 | +1.57 (+156.8%) |
78 ratings from 14 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Hold | $1 $11 | Oct 22, 2026 |
| Jefferies | Maintained | Hold | $0.85 $11 | Oct 19, 2026 |
| TD Cowen | Maintained | Hold | $1 $0.9 | Aug 12, 2026 |
| Roth Capital | Reiterated | Buy | $2.5 $2 | May 20, 2026 |
| Canaccord Genuity | Maintained | Hold | $1.5 $1 | May 1, 2026 |
| TD Cowen | Maintained | Hold | $1.65 $1.5 | Mar 16, 2026 |
| Canaccord Genuity | Maintained | Hold | $1.5 | Mar 13, 2026 |
| TD Cowen | Maintained | Hold | $1.5 $1.65 | Jan 21, 2026 |
| TD Cowen | Maintained | Hold | $2 $2.5 | Sep 22, 2025 |
| Roth Capital | Initiated | Buy | $3.5 | Sep 19, 2025 |
| Canaccord Genuity | Maintained | Hold | $1.5 $1.25 | May 5, 2025 |
| Canaccord Genuity | Maintained | Hold | $1.75 $1.5 | Mar 13, 2025 |
| Canaccord Genuity | Maintained | Hold | $1.25 $1.75 | Nov 13, 2024 |
| Canaccord Genuity | Maintained | Hold | $2 $1.25 | Aug 12, 2024 |
| Piper Sandler | Reiterated | Underweight | $1.5 $1 | Aug 9, 2024 |
| Stifel | Maintained | Hold | $4 $2 | Jul 26, 2024 |
| Piper Sandler | Maintained | Underweight | $2.5 $1.5 | Jul 11, 2024 |
| DA Davidson | Maintained | Buy | $5 | May 13, 2024 |
| TD Cowen | Maintained | Hold | $4 $3 | May 13, 2024 |
| Piper Sandler | Maintained | Underweight | $3 $2.5 | May 10, 2024 |
| DA Davidson | Maintained | Buy | $5 | Mar 15, 2024 |
| Canaccord Genuity | Maintained | Hold | $3 $4 | Mar 14, 2024 |
| Stifel | Reiterated | Hold | $3 $4 | Mar 13, 2024 |
| TD Cowen | Maintained | Market Perform | $2.5 $4 | Mar 13, 2024 |
| Piper Sandler | Reiterated | Underweight | $2 $3 | Mar 13, 2024 |
19 filings from 13 insiders · 77 buy / 1 sell over 6m
Officers and directors of SKIN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Malha Pedro Bruno FerreiraDirector; Officer, President and CEO | Tax | 78.0k | $0.55 | $43k | Oct 9, 2026 |
| Malha Pedro Bruno FerreiraDirector; Officer, President and CEO | Tax | 99.7k | $0.55 | $55k | Oct 9, 2026 |
| MALHA PEDRO BRUNO FERREIRAChief Executive Officer | Grant | 2.65M | — | — | Mar 20, 2026 |
| LEWIS SHERIChief Operating Officer | Grant | 746.7k | — | — | Mar 20, 2026 |
| MENEZES RONALDOfficer | Grant | 746.7k | — | — | Mar 20, 2026 |
| MONAHAN MICHAEL PChief Financial Officer | Grant | 746.7k | — | — | Mar 20, 2026 |
| SCHAISON PHILIPPEDirector | Grant | 57.7k | — | — | Nov 13, 2025 |
| MALHA PEDRO BRUNO FERREIRAChief Executive Officer | Grant | 2.19M | $1.56 | $3.42M | Oct 9, 2025 |
| MILLER BRIAN CHRISTOPHERDirector | Grant | 73.1k | — | — | Jun 16, 2025 |
| SCHILLINGER DOUG K.Director | Grant | 73.1k | — | — | Jun 16, 2025 |
| GRUBER DESIREEDirector | Grant | 73.1k | — | — | Jun 16, 2025 |
| KERRICK MICHELLE C.Director | Grant | 73.1k | — | — | Jun 16, 2025 |
| SAUNDERS BRENT L.Chairman of the Board | Grant | 73.1k | — | — | Jun 16, 2025 |
| FANNING STEPHEN JDirector | Grant | 73.1k | — | — | Jun 16, 2025 |
| LEWIS SHERIChief Operating Officer | Grant | 639.2k | $1.32 | $844k | Mar 17, 2025 |
| MENEZES RONALDOfficer | Grant | 639.2k | $1.32 | $844k | Mar 17, 2025 |
| BECK MARLA MALCOLMChief Executive Officer | Grant | 1.83M | $1.32 | $2.42M | Mar 17, 2025 |
| MONAHAN MICHAEL PChief Financial Officer | Grant | 639.2k | $1.32 | $844k | Mar 17, 2025 |
| GRUBER DESIREEDirector | Sell | 14.7k | $1.50 | $22k | Nov 20, 2024 |
Members whose judged calls on SKIN have played out most reliably.
No settled calls on SKIN yet. 1 call is open, the first due Sep 5, 2027.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
6 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 1 | 6 | 0 | 2 | Hold3.33 |
| 1 mo ago | 0 | 1 | 6 | 0 | 2 | Hold3.33 |
| 2 mo ago | 0 | 1 | 6 | 0 | 2 | Hold3.33 |